AIDS Vaccines (Industry News)

Cooperative Agreement for Candidate HIV/AIDS Vaccine Announced

Published in Vaccine Weekly, February 9th, 2000

Avant Immunotherapetics, Inc., announced that it has entered into a Cooperative Research and Development Agreement (CRADA) with the Walter Reed Army Institute of Research (WRAIR) for the use of Therapore^TM-P24 in the development of a vaccine candidate against the human immunodeficiency virus (HIV).

Under the CRADA, Avant will provide its proprietary Therapore technology to generate specific immune responses against the HIV genomic sequence. Experts believe that an immune response created by a vaccine against the gene carried inside HIV has the potential to prevent infection by the virus and subsequently to protect individuals from developing acquired...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (2000-02-09)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry